Holen Sie sich die Stockscreener-App
36.08
0.14%
-0.05
Handel nachbörslich:
36.08
Schlusskurs vom Vortag:
$36.13
Offen:
$36.32
24-Stunden-Volumen:
607.56K
Relative Volume:
0.57
Marktkapitalisierung:
$2.68B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-275.16M
KGV:
-7.4086
EPS:
-4.87
Netto-Cashflow:
$-221.15M
1W Leistung:
-2.85%
1M Leistung:
-13.83%
6M Leistung:
-3.19%
1J Leistung:
-1.15%
1-Tages-Spanne:
$35.99
$37.88
1-Wochen-Bereich:
$35.39
$37.88
52-Wochen-Spanne:
$28.21
$53.92
Springworks Therapeutics Inc Stock (SWTX) Company Profile
Firmenname
Springworks Therapeutics Inc
Sektor
Branche
Telefon
203-883-9490
Adresse
100 WASHINGTON BOULEVARD, STAMFORD, CT
Vergleichen Sie SWTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
36.08 | 2.68B | 0 | -275.16M | -221.15M | -3.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.76 | 104.50B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.19 | 78.59B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
620.16 | 37.08B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.62 | 30.13B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
115.30 | 27.64B | 3.30B | -501.07M | 1.03B | -2.1146 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-20 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-05 | Eingeleitet | Guggenheim | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-05 | Eingeleitet | Barclays | Overweight |
| 2020-03-19 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-10-08 | Eingeleitet | Cowen | Outperform |
| 2019-10-08 | Eingeleitet | Goldman | Buy |
| 2019-10-08 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Springworks Therapeutics Inc Aktie (SWTX) Neueste Nachrichten
SpringWorks: With Catalyst On The Horizon And Growing Sales, 2025 Looks Great - Seeking Alpha
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $69.50 Consensus Target Price from Brokerages - Defense World
How To Trade (SWTX) - Stock Traders Daily
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Principal Financial Group Inc. Has $29.43 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Stifel Financial Corp Reduces Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Low Grade Glioma Market Predicted to See Upsurge Through 2034, - openPR
Geode Capital Management LLC Has $53.53 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Barclays PLC Raises Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
(SWTX) On The My Stocks Page - Stock Traders Daily
Comparing Titan Pharmaceuticals (NASDAQ:TTNP) & SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm - GuruFocus.com
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks - Seeking Alpha
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress By Investing.com - Investing.com South Africa
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress - Investing.com India
Lord Abbett & CO. LLC Has $34.27 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.20 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Up 14.5% Since Last Earnings Report: Can It Continue? - MSN
Main Management ETF Advisors LLC Buys Shares of 23,280 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Charles Schwab Investment Management Inc. Raises Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Trading Report - Stock Traders Daily
Soros Fund Management LLC Acquires 174,321 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Insider Sell Alert: Badreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics Inc (SWTX) - GuruFocus.com
Springworks Therapeutics COO sells $839,335 in stock By Investing.com - Investing.com UK
Erste Asset Management GmbH Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock - Investing.com
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock By Investing.com - Investing.com Nigeria
Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX) - GuruFocus.com
High Growth Tech Stocks to Watch in December 2024 - Simply Wall St
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Position Boosted by The Manufacturers Life Insurance Company - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by HighVista Strategies LLC - MarketBeat
Are Investors Eager To Sell Holdings In SpringWorks Therapeutics Inc (NASDAQ: SWTX)? - Stocks Register
Walleye Capital LLC Boosts Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Fmr LLC Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Intech Investment Management LLC Invests $676,000 in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Dynamic Technology Lab Private Ltd Buys Shares of 13,717 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Ally Bridge Group NY LLC Invests $7.30 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Present at Evercore ISI HealthCONx Conference | SWTX Stock News - StockTitan
Massachusetts Financial Services Co. MA Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Investment Analysis - Stock Traders Daily
SpringWorks Therapeutics' SWOT analysis: stock shows promise amid challenges - Investing.com
Alpha DNA Investment Management LLC Makes New $411,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
GSA Capital Partners LLP Makes New $209,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Vertex leads J.P. Morgan's top biotech picks list for 2025 (NASDAQ:VRTX) - Seeking Alpha
Eagle Asset Management Inc. Sells 54,366 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Trading 8.1% HigherShould You Buy? - MarketBeat
SpringWorks Therapeutics Inc. (SWTX): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
Evercore ISI Begins Coverage on SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
Finanzdaten der Springworks Therapeutics Inc-Aktie (SWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):